Literature DB >> 7879413

Direct gene transfer into muscle.

I Danko1, J A Wolff.   

Abstract

Gene therapy has great promise for the treatment and the prevention of a broad range of inherited and acquired diseases. Gene transfer methods currently explored include the use of viral vectors and physical-chemical methods. Plasmid DNA can be taken up by skeletal muscle cells in vivo without any special delivery mechanism and persist long-term in an extrachromosomal, non-replicative circular form. Thus, foreign genes can be expressed permanently in skeletal muscle. At present the efficiency of gene transfer is not high enough to treat genetic muscle diseases. However, even at the relatively low efficiency of expression we are able to achieve at present, plasmid DNA transfer seems to be a very promising way of programming cells in vivo to secrete proteins for immunization purposes.

Entities:  

Mesh:

Year:  1994        PMID: 7879413     DOI: 10.1016/0264-410x(94)90072-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Genetic fate of recombinant adeno-associated virus vector genomes in muscle.

Authors:  Bruce C Schnepp; K Reed Clark; Dori L Klemanski; Christina A Pacak; Philip R Johnson
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.

Authors:  Waithaka Mwangi; Wendy C Brown; Gary A Splitter; Christopher J Davies; Chris J Howard; Jayne C Hope; Yoko Aida; Yan Zhuang; Beverly J Hunter; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

3.  A differential proteome in tumors suppressed by an adenovirus-based skin patch vaccine encoding human carcinoembryonic antigen.

Authors:  Chun-Ming Huang; Zhongkai Shi; Tivanka S DeSilva; Masato Yamamoto; Kent R Van Kampen; Craig A Elmets; De-chu C Tang
Journal:  Proteomics       Date:  2005-03       Impact factor: 3.984

Review 4.  Gene transfer by biolistic process.

Authors:  P A Furth
Journal:  Mol Biotechnol       Date:  1997-04       Impact factor: 2.695

5.  Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity.

Authors:  W Shi; P Bu; J Liu; A Polack; S Fisher; L Qiao
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 6.  New strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genes.

Authors:  Jozef Dulak; Anna Zagorska; Barbara Wegiel; Agnieszka Loboda; Alicja Jozkowicz
Journal:  Cell Biochem Biophys       Date:  2006       Impact factor: 2.194

7.  DNA Vaccines for Prostate Cancer.

Authors:  Douglas G McNeel; Jordan T Becker; Laura E Johnson; Brian M Olson
Journal:  Curr Cancer Ther Rev       Date:  2012-11-01

8.  Efficient induction of T helper type 1-mediated immune responses in antigen-primed mice by anti-CD3 single-chain Fv/interleukin-18 fusion DNA.

Authors:  E J Kim; D Cho; T S Kim
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

9.  Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct.

Authors:  Y S Lim; B Y Kang; E J Kim; S H Kim; S Y Hwang; T S Kim
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

10.  Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection.

Authors:  Emmalene J. Bartlett; Vanessa S. Cull; Eva N. Mowe; Josephine P. Mansfield; Cassandra M. James
Journal:  Biol Proced Online       Date:  2003-02-17       Impact factor: 3.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.